Managers

Emerging managers rope $624 mln, led by Pace Capital and Vertex Ventures: Exclusive

Stratasan attracts $26 mln

Nashville-based Stratasan LLC, a healthcare data analytics software provider, has secured $26 million in funding. Fulcrum Equity Partners led the round.

One BioMed scores $5 mln Series A

Singapore-based One BioMed Pte Ltd, a medical diagnostics company, has raised $5 million in Series A financing round. Biopath Ventures and ARCH Venture Partners led the round with participation from SEEDS Capital.

Amazon innovation, robotics revolution growing warehouse automation at fast clip

AblaCare takes in Series A

Paris-based AblaCare, a medical device firm focused on women's health and fertility care, has secured 10 million euros in Series A funding. The investor was Sofinnova Partners.

Canadian venture capital and startup predictions for 2019: an update

IGM Biosciences amasses $102 mln Series C

Mountain View, California-based IGM Biosciences Inc, a biotech firm focused on developing engineered IgM antibodies for therapeutic use, has raised $102 million in Series C financing. The investors included Redmile Group, Janus Henderson Investors and Vivo Capital.

BioNTech procures $325 mln Series B

BioNTech SE, a German biotech company focused on treating cancer and other serious diseases, has raised $325 million in Series B funding. Fidelity Management & Research Company was the lead investor.

Avestria targets $50 mln for inaugural fund

Avestria Ventures is seeking to raise $50 million for its debut fund, according to an SEC filing. The California-based venture firm invests in early-stage women's health and life science companies.

GNS Healthcare inks $23 mln Series D

Cambridge, Massachusetts-based GNS Healthcare, a precision medicine company, has raised $23 million in Series D funding round. Cigna Ventures led the round.